Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial

OBJECTIVE: To investigate the safety and feasibility of 3 nonconsecutive days of intermittent fasting (IF) per week over 12 weeks in participants with insulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: Forty-six people were randomized to an IF or control group. Dietary counseling and cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Obermayer, Anna, Tripolt, Norbert J., Pferschy, Peter N., Kojzar, Harald, Aziz, Faisal, Müller, Alexander, Schauer, Markus, Oulhaj, Abderrahim, Aberer, Felix, Sourij, Caren, Habisch, Hansjörg, Madl, Tobias, Pieber, Thomas, Obermayer-Pietsch, Barbara, Stadlbauer, Vanessa, Sourij, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887629/
https://www.ncbi.nlm.nih.gov/pubmed/36508320
http://dx.doi.org/10.2337/dc22-1622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887629/
https://www.ncbi.nlm.nih.gov/pubmed/36508320
http://dx.doi.org/10.2337/dc22-1622

Ejemplares similares